Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dannel Yeo

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Pancreas|March 12, 2015
The role of p21-activated kinases in pancreatic cancerDannel Yeo, Hong He, Graham S Baldwin, et al.
Molecular Therapy Oncolytics|March 1, 2022
The next wave of cellular immunotherapies in pancreatic cancerDannel Yeo, Caroline Giardina, Payal Saxena, et al.
Cancers|August 27, 2021
Hitting the Bull's-Eye: Mesothelin's Role as a Biomarker and Therapeutic Target for Malignant Pleural MesotheliomaDannel Yeo, Laura Castelletti, Nico van Zandwijk, et al.
Biomarker Research|February 16, 2021
Anti-Mesothelin CAR T cell therapy for malignant mesotheliomaLaura Castelletti, Dannel Yeo, Nico van Zandwijk, et al.
International Journal of Cancer|January 22, 2017
Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancerDannel Yeo, Phoebe Phillips, Graham S Baldwin, et al.
The Journal of Liquid Biopsy|March 3, 2025
Cancer-associated macrophage-like cells as a prognostic biomarker in solid tumorsAnthony Pirrello, Murray Killingsworth, Kevin Spring, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2024
Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancerHelen Ke, Steven Kao, Nico van Zandwijk, et al.
BMC Cancer|January 18, 2016
FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabineDannel Yeo, Hong He, Oneel Patel, et al.
International Journal of Molecular Sciences|February 15, 2022
Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor CellsDannel Yeo, Althea Bastian, Heidi Strauss, et al.
International Journal of Cancer|February 3, 2022
Mapping oncogenic protein interactions for precision medicineMehdi Sharifi Tabar, Habib Francis, Dannel Yeo, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pancreas|March 12, 2015
The role of p21-activated kinases in pancreatic cancerDannel Yeo, Hong He, Graham S Baldwin, et al.
Molecular Therapy Oncolytics|March 1, 2022
The next wave of cellular immunotherapies in pancreatic cancerDannel Yeo, Caroline Giardina, Payal Saxena, et al.
Cancers|August 27, 2021
Hitting the Bull's-Eye: Mesothelin's Role as a Biomarker and Therapeutic Target for Malignant Pleural MesotheliomaDannel Yeo, Laura Castelletti, Nico van Zandwijk, et al.
Biomarker Research|February 16, 2021
Anti-Mesothelin CAR T cell therapy for malignant mesotheliomaLaura Castelletti, Dannel Yeo, Nico van Zandwijk, et al.
International Journal of Cancer|January 22, 2017
Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancerDannel Yeo, Phoebe Phillips, Graham S Baldwin, et al.
The Journal of Liquid Biopsy|March 3, 2025
Cancer-associated macrophage-like cells as a prognostic biomarker in solid tumorsAnthony Pirrello, Murray Killingsworth, Kevin Spring, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2024
Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancerHelen Ke, Steven Kao, Nico van Zandwijk, et al.
BMC Cancer|January 18, 2016
FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabineDannel Yeo, Hong He, Oneel Patel, et al.
International Journal of Molecular Sciences|February 15, 2022
Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor CellsDannel Yeo, Althea Bastian, Heidi Strauss, et al.
International Journal of Cancer|February 3, 2022
Mapping oncogenic protein interactions for precision medicineMehdi Sharifi Tabar, Habib Francis, Dannel Yeo, et al.
Pageof 3